Using prostate cancer as an exemplar, we showed that acquisition of pluripotent master regulators drove castration resistance independent from conventional AR related signalling and uncovered the TH pathway as a new treatment target for castration-resistant disease. The gene discussed is TH; the disease is prostate cancer.